BOSTON, August 5, 2015 /PRNewswire/- Aurigene will be presenting data at the poster session for its proprietary RAR-related orphan receptor gamma (RORγ) small molecule inverse agonists program, which is currently in preclinical
LEXINGTON, Mass. and Bangalore, India, January 21, 2015 (GLOBENEWSWIRE) — Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of
